↓ Skip to main content

Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial

Overview of attention for article published in Alzheimer's Research & Therapy, January 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news
1 news outlet

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
Published in
Alzheimer's Research & Therapy, January 2023
DOI 10.1186/s13195-023-01163-3
Pubmed ID
Authors

Glen Wunderlich, Zuzana Blahova, Miguel Garcia, Frank Jessen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 8%
Lecturer 1 4%
Student > Bachelor 1 4%
Professor 1 4%
Student > Master 1 4%
Other 2 8%
Unknown 16 67%
Readers by discipline Count As %
Medicine and Dentistry 4 17%
Unspecified 2 8%
Neuroscience 1 4%
Computer Science 1 4%
Unknown 16 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 February 2023.
All research outputs
#4,299,207
of 23,344,526 outputs
Outputs from Alzheimer's Research & Therapy
#940
of 1,270 outputs
Outputs of similar age
#74,688
of 399,588 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#35
of 65 outputs
Altmetric has tracked 23,344,526 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,270 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.9. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.